SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 44198
 
 
 
C07K PEPTIDES 2286
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 20135
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 16160
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1462
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13105
 
 
 
C07D HETEROCYCLIC COMPOUNDS 9140
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 696
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 483
 
 
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 426

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0256,753 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONSAug 10, 12Sep 11, 14[C07D]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYDec 17, 13Aug 28, 14[C12N, G01N]
2014/0235,582 HIV REPLICATION INHIBITORSAug 27, 12Aug 21, 14[C07D, A61K]
2014/0220,106 LYMPHATIC ZIP CODES IN TUMORS AND PRE-MALIGNANT LESIONSSep 13, 13Aug 07, 14[G01N, C07K]
2014/0221,612 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsNov 27, 13Aug 07, 14[A61K]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAMar 15, 13May 15, 14[C12N, C12Q, A61K]
2014/0005,181 SMALL MOLECULE ANTAGONISTS OF THE APELIN RECEPTOR FOR THE TREATMENT OF DISEASEJun 20, 13Jan 02, 14[C07D]
2013/0343,989 Methods and Compositions Related to Internalizing RGD PeptidesJan 30, 13Dec 26, 13[A61K, C07K]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USESep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSNov 07, 12Aug 29, 13[C12Q, G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,815,804 Methods and compositions related to targeting tumors and woundsFeb 05, 07Aug 26, 14[A61K, C07K]
8,785,499 Targeting NAD biosynthesis in bacterial pathogensJul 12, 10Jul 22, 14[A61K]
8,753,604 Methods and compositions for synaphically-targeted treatment for cancerDec 23, 09Jun 17, 14[A61K]
8,748,632 Positive allosteric modulators of group II mGluRsMar 18, 11Jun 10, 14[C07D, A61K]
8,686,003 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcificationDec 07, 11Apr 01, 14[A61K]
8,642,283 Screening assay for agents that alter target of rapamycin activityMay 26, 06Feb 04, 14[C12Q, G01N]
8,637,635 Peptides that selectively home to heart vasculature and related conjugates and methodsJan 29, 09Jan 28, 14[A61K, C07K]
8,598,316 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignanciesMar 26, 10Dec 03, 13[A61K]
8,536,132 Lymphatic zip codes in tumors and pre-malignant lesionsFeb 10, 11Sep 17, 13[A61P, A61K]
8,506,965 R-RAS activity in vascular regulationNov 11, 05Aug 13, 13[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USESep 28, 11Aug 29, 13[C07K]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISDec 02, 10Jun 20, 13[G01N]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]
2012/0196,922 ZNF206: A NOVEL REGULATOR OF EMBRYONIC STEM CELL SELF-RENEWAL AND PLURIPOTENCYDec 05, 11Aug 02, 12[C12N, C07H, C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0190,615 METHODS AND COMPOSITIONS FOR INDUCING WEIGHT LOSSJan 18, 12Jul 26, 12[A61P, A61K]
2012/0094,922 SCREENING ASSAYS FOR AGENTS THAT ALTER INHIBITOR OF APOPTOSIS (IAP) PROTEIN REGULATION OF CASPASE ACTIVITYNov 02, 11Apr 19, 12[A61P, C12Q, G01N, A61K]
2012/0095,032 METHODS FOR TREATING LEUKEMIA AND MYELODYSPLASTIC SYNDROME, AND METHODS FOR IDENTIFYING AGENTS FOR TREATING SAMEDec 06, 11Apr 19, 12[C12N, A61P, A61K]
2012/0088,678 METHOD FOR PREDICTION OF RESPONSE TO RHEUMATOID ARTHRITIS THERAPEUTICSSep 08, 11Apr 12, 12[C40B, C12Q, G01N]
2012/0088,771 TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP): A THERAPEUTIC TARGET FOR ARTERIAL CALCIFICATIONOct 11, 11Apr 12, 12[C07D, A61P, C07C, A61K]
2012/0071,629 APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCERJul 20, 11Mar 22, 12[C07H, C07K]
2012/0046,195 DETECTING BCL-B EXPRESSION IN CANCER AND USES THEREOFOct 31, 11Feb 23, 12[C40B, C12Q, G01N]
2012/0046,329 MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOFAug 10, 11Feb 23, 12[C12N, C40B, A61P, A61K]
2012/0046,446 p16 MEDIATED REGULATION OF NMDA RECEPTORSAug 12, 11Feb 23, 12[C07H, C07K]
2012/0014,974 METHODS OF MODULATING CELL DEATH BASED ON THE BIT1/AES REGULATORY PATHWAYJun 06, 11Jan 19, 12[A61P, C12Q, A61K]
2011/0318,362 NOVEL CARD PROTEINS INVOLVED IN CELL DEATH REGULATIONAug 08, 11Dec 29, 11[C12N, A61P, G01N, A61K, C07K]
2011/0311,616 TARGETING TUMOR ASSOCIATED MACROPHAGES USING BISPHOSPHONATE-LOADED PARTICLESJun 16, 11Dec 22, 11[A61P, A61K, B82Y]
2011/0301,095 METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING METASTASIS, METASTATIC CANCER, AND POTENTIAL FOR METASTASISJun 06, 11Dec 08, 11[C40B, A61P, C12Q, G01N, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.